Phase 3 Trial of Interleukin-1 Trap Rilonacept in Recurrent Pericarditis

N Engl J Med. 2021 Apr 15;384(15):1474-1475. doi: 10.1056/NEJMc2101978.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Gout Suppressants* / therapeutic use
  • Humans
  • Pericarditis* / diagnostic imaging
  • Pericarditis* / drug therapy
  • Recombinant Fusion Proteins / therapeutic use

Substances

  • Gout Suppressants
  • Recombinant Fusion Proteins
  • rilonacept